Suppr超能文献

正溴乙酰基-β-D-半乳糖胺对人肝脏β-半乳糖苷酶和β-葡萄糖苷酶的抑制作用

Inhibition of human liver beta-galactosidases and beta-glucosidase by n-bromoacetyl-beta-D-galactosylamine.

作者信息

Meisler M H

出版信息

Biochim Biophys Acta. 1975 Dec 18;410(2):347-53. doi: 10.1016/0005-2744(75)90236-3.

Abstract

N-Bromoacetyl-beta-D-galactosylamine is an irreversible inhibitor of the 'acid' and the 'neutral' beta-galactosidases (beta-D-galactoside galactohydrolase, EC 3.2.1.23) of human liver. The inactivation of acid beta-galactosidase appears to involve a group with a pKa = 4.5. The inhibition of neutral beta-galactosidase only occurs above pH 8.0. Both enzymes are protected against inhibition by the presence of substrates, suggesting that the inhibitor reacts with the active site of the enzymes. Other lysosomal hydrolases are not inhibited by N-bromoacetyl-beta-D-galactosylamine, with the exception of 'neutral' beta-glucosidase (beta-D-glucoside glucohydrolase, EC 3.2.1.21). The pH dependence of neutral beta-glucosidase inactivation is essentially identical to that of the neutral beta-galactosidase. Inhibition of beta-glucosidase by this galactose derivative suggests that the same enzyme may bind glucosides and galactosides. Furthermore, both neutral beta-galactosidase and beta-glucosidase are inactivated at 52 degrees C with a half-life of 7.5 min. The presence of a single enzyme with both beta-glucosidase and beta-galactosidase activities is also supported by mixed-substrate experiments.

摘要

N-溴乙酰基-β-D-半乳糖胺是人类肝脏中“酸性”和“中性”β-半乳糖苷酶(β-D-半乳糖苷半乳糖水解酶,EC 3.2.1.23)的不可逆抑制剂。酸性β-半乳糖苷酶的失活似乎涉及一个pKa = 4.5的基团。中性β-半乳糖苷酶的抑制仅在pH 8.0以上发生。两种酶在有底物存在时都受到抑制保护,这表明抑制剂与酶的活性位点发生反应。除了“中性”β-葡萄糖苷酶(β-D-葡萄糖苷葡萄糖水解酶,EC 3.2.1.21)外,其他溶酶体水解酶不受N-溴乙酰基-β-D-半乳糖胺的抑制。中性β-葡萄糖苷酶失活的pH依赖性与中性β-半乳糖苷酶基本相同。这种半乳糖衍生物对β-葡萄糖苷酶的抑制表明,同一种酶可能结合葡萄糖苷和半乳糖苷。此外,中性β-半乳糖苷酶和β-葡萄糖苷酶在52℃下失活,半衰期为7.5分钟。混合底物实验也支持存在一种同时具有β-葡萄糖苷酶和β-半乳糖苷酶活性的单一酶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验